#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Atopic keratoconjunctivitis Endocrine ophthalmopathy B-cell small lymphocytic lymphoma refractory Neuroblastoma Malignant peritoneal neoplasm Alveolar proteinosis Neurodevelopmental disorder Craniocerebral injury Dent's disease Burkitt's lymphoma refractory Neuromyelitis optica spectrum disorder Fragile X syndrome Mitochondrial encephalomyopathy Frontotemporal dementia Vernal keratoconjunctivitis More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors – Trials in Disease Cholangitis sclerosing – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Basic Information Glycogen storage disease type I – Basic Information CADASIL – Diagnostics Factor VIII deficiency Glycogen storage disease type V Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Stevens-Johnson syndrome – Treatment X-linked lymphoproliferative syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cangrelor Tetrasodium Pivmecillinam Hydrochloride Acalabrutinib Nitrofurantoin Atomoxetine Hydrochloride 177LU-PSMA-I&T Disulfiram Azd5004 Chlorphenamine Maleate Contezolid Giroctocogene Fitelparvovec 11902A RO7284755 Pariglasgene Brecaparvovec TEDUGLUTIDE Indapamide Milrinone Tildacerfont Paraffin White Soft Maraviroc More therapies…

    Learn about Your Condition

    Dent's disease Asthma Biliary neoplasm Hepatobiliary disease Colitis ulcerative Chronic myeloid leukaemia Cerebral palsy Athetosis Narcolepsy Ejection fraction normal Carcinoid tumour pulmonary Corneal dystrophy Neonatal hyperglycaemia Osteoporosis Carcinoid syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study of dexmedetomidine versus placebo to reduce opioid use in premature babies requiring mechanical ventilation for respiratory distress

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Mechanical ventilation
    Investigated Drugs:
    • Dexmedetomidine
    • Glucose
    France

  • Testing Gene Therapy AAV9/AP4M1 in Patients with Hereditary Spastic Paraplegia Type 50

    Not yet recruiting

    2 1 1
    Italy

  • Study of sodium butyrate enemas for bowel function recovery after surgery in children and adults with Hirschsprung’s disease

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Butyrate
    France

  • A Study Testing the Safety and Tolerability of ALE1 in Healthy Adults and Adults with Hypophosphatasia

    Not yet recruiting

    2 1
    Investigated Drugs:
    • ALE1
    Germany

  • A study of mirdametinib for infants and toddlers under 24 months of age with neurofibromatosis type 1 associated plexiform neurofibromas

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Germany Spain

  • Cannabidiol for behavioral problems in patients with Tuberous Sclerosis Complex, Sanfilippo syndrome, and Fragile X syndrome

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Cannabidiol
    The Netherlands
Previous Page
1 … 20 21 22 23 24 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!